XML 27 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note 9 - Related Party Transactions
9 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
Note
9
– Related Party Transactions
 
As of
December 31, 2019
, the Company is indebted to its officers for a total of
$324,738,
consisting of
$142,637
in unpaid wages,
$75,747
in unpaid bonuses, and
$106,354
of reimbursements for business expenses.
 
In connection with the sale of membership interest in GB Sciences Louisiana, LLC, the Company issued a note payable in the amount of
$151,923
to John Davis, the Company's former General Counsel and President of GB Sciences Louisiana, LLC, for unpaid fees and bonuses. The note matures upon receipt of the
first
payment from the Wellcana Note Receivable (Note
10
).
 
During the fiscal year ended
March 31, 2017,
the Company entered into a consulting contract with Quantum Shop, a Company owned by a relative of
one
of the Company’s executives. Quantum Shop provided GB Sciences with research, design, development, fabrication, and production services. During the
nine
months ended
December 31, 2018,
the Company made payments totaling
$1.1
million to Quantum Shop primarily related to the build-out of the cultivation and production facility in Baton Rouge, Louisiana owned by GB Sciences Louisiana, LLC.
 
During the year ended
March 31, 2017,
the Company entered into an advisory agreement with Electrum Partners, LLC, a company whose President resides on GB Sciences’ Board of Directors and serves as a Chair of the Audit Committee. The agreement has a term of
one
year and was renewed for a successive
one
-year period on
March 31, 2018. 
During the
nine
months ended
December 31, 2018,
the Company made payments totaling
$73,904
to Electrum Partners, LLC and issued
285,412
shares of its restricted stock at an expense of
$99,596.
Subsequent to
December 31, 2018,
the Company terminated the advisory agreement.
 
On
November 1, 2017,
the Company entered into an Edibles Production Agreement (the “EPA”) with The Happy Confections, L.L.C. (“THCLLC”) through the Company’s wholly-owned subsidiary, GB Sciences Las Vegas, LLC (“GBLV”). A member of GB Science’s Board of Directors is a Co-Managing Member of THCLLC. Under the EPA, THCLLC was to produce cannabis-infused baked goods and other edibles in GBLV’s production facility. The Company will receive a royalty of between
20%
and
25%
on all sales of edibles produced by THCLLC.
 
Contemporaneously with the EPA, the Company entered into a Non-Revolving Credit Line Agreement and Non-Revolving Credit Line Promissory Note (together, the “THC Note” or “Note”) to advance up to
$300,000
to THCLLC for the purpose of expanding THCLLC’s operations. Beginning
90
days after the sale of its
first
product, THCLLC was to make repayment of its advances under the Note in an amount equal to
25%
of its gross sales revenue.
 
As of
December 31, 2018,
the Company had advanced
$253,034
under the THC Note. The Company terminated the Edibles Production Agreement and all other related agreements with THC LLC effective
October 19, 2018
and took possession of all tangible assets owned by THCLLC on
October 22, 2018,
as collateral for the balance owed under the Note. These assets included kitchen and production equipment, leasehold improvements, and inventory used in Company’s production operations at the Teco Facility.
 
The Company assessed the fair value of the machinery and equipment received at
$139,411
and capitalized that amount in fixed assets during the quarter ended
December 31, 2018.
All of the machinery and equipment received from THC LLC was placed in service for use in the Company’s production facility. The Company recorded
$
113,623
as other expense in its Condensed Consolidated Statement of Operations for the
three
and
nine
months ended
December 31, 2018,
which represents the remaining balance of the outstanding note receivable from THC LLC.